“…Evidence from clinical trials evaluating metacognitive therapy (MCT; Wells, 2009) which directly targets metacognitive beliefs brings further support for a role of metacognition to quality of life as MCT is associated with improvement in quality of life among patients being treated for depression (Solem, Kennair, Hagen et al ., 2019), anxiety and depression in the context of cancer (Fisher, Byrne, Fairburn, Ullmer, Abbey & Salmon, 2019), prolonged grief (Wenn, O'Connor, Kane, Rees & Breen, 2019) and repetitive thinking (McEvoy, Erceg‐Hurn, Anderson et al ., 2015). MCT is also associated with improved self‐confidence and self‐efficacy in patients at risk of sick leave due to mental problems (Bjørndal, Giæver, Aschim et al ., 2022). In sum, the existing literature indicates a role for metacognitions in quality of life, and a more specific evaluation of these relationships is warranted.…”